Revvity, Inc. reaffirmed earnings guidance for the full year 2024. For the period, the company expects total revenue of $2.79 billion to $2.85 billion.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
114 USD | +0.71% | +6.08% | +4.14% |
May. 14 | Transcript : Revvity, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM | |
Apr. 30 | TD Cowen Adjusts Price Target on Revvity to $130 From $123 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.14% | 13.97B | |
+12.04% | 225B | |
+15.94% | 197B | |
+19.50% | 143B | |
+31.24% | 111B | |
+2.93% | 64.72B | |
+19.80% | 54.44B | |
+5.12% | 51.06B | |
+10.76% | 45.03B | |
+4.87% | 37.4B |
- Stock Market
- Equities
- RVTY Stock
- News Revvity, Inc.
- Revvity, Inc. Re-Affirms Earnings Guidance for the Full Year 2024